This is a limitation to the hypothesis that different rates of adrenal-permissive genotype contribute to different rates of ER-positive versus -negative breast cancer in patients of different ancestries and suggests that other aspects of race and ancestry also influence rates of ER positivity. Here, ESR1 is linked to breast carcinoma.